NYU Langone Medical Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NYU Langone Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9297
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NYU Langone Medical Center (NYU LMC) a subsidiary of New York University School of Medicine is an academic healthcare center that provides patient care, education and research services. The center offers patient care services such as patient and family support; imaging services, medical services, emergency care; and insurance and billing. It provides medical degree programs, clinical trials, masters degree programs, medical training, postgraduate medical education courses, research training and fellowship training program. NYU LMC offers treatment for the therapeutic areas which includes centeral nervous system disorders, heart and vascular conditions, pediatric conditions, skin and cosmetic conditions, and others. The center operates through institutes and medical centers located in Long Island, New Jersey, and Westchester, Putnam, and Dutchess counties. NYU LMC is headquartered in New York, the US.

NYU Langone Medical Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NYU Langone Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
NYU Langone Medical Center, Medical Devices Deals, 2012 to YTD 2018 10
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Vedanta Biosciences Enters into Agreement with NYU Langone Medical Center 12
Vedanta Biosciences Expands Agreement with NYU Langone Medical 13
Acquisition 14
NYU Langone Medical Center Acquires Huntington Medical 14
NYU Langone Medical Center – Key Competitors 15
NYU Langone Medical Center – Key Employees 16
NYU Langone Medical Center – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
May 21, 2018: NYU Langone’s Center for Stroke and Neurovascular Diseases Launches as Destination for Complex Care 18
Nov 01, 2017: Bristol-Myers Squibb, BioLabs Announce Founding Sponsorship in Support of Promising Biotech Companies in New York 20
Oct 26, 2017: Lung Cancer Research And Clinical Care The Focus Of New Center At NYU Langone Health 21
Jun 26, 2017: NYU Langone to Launch Center for Biotech Startups in Manhattan 22
Government and Public Interest 23
Sep 26, 2018: Hyundai Hope On Wheels Presents NYU Langone Health With $300,000 Hyundai Hope Scholar Grant To Support Pediatric Cancer Research 23
Jul 18, 2018: Heart attack risk on the rise for pregnant women and death rate remains high 24
Jun 22, 2018: Broken Shuttle May Hinder Learning across Several Brain Disorders 25
May 15, 2018: VA Health Care System Successfully Reduces “Rush to Treatment” Rates for Low-Risk Prostate Cancer, Study Shows 27
May 14, 2018: Identifying PTSD Could Be Adversely Affected Under Proposed Changes To Diagnostic Tool Used Worldwide 29
Mar 06, 2018: Study Validates Software Tool to Assess Mortality Risk in Older Patients with Orthopedic Fractures 30
Jan 17, 2018: Researchers Discover Structure of Anti-Aging Hormone 31
Nov 27, 2017: Changes in Bacterial Mix Linked to Antibiotics Increase Risk for Inflammatory Bowel Disease 33
Oct 02, 2017: Transcranial Direct Current Stimulation Shown to Reduce Fatigue Associated with Multiple Sclerosis 34
Sep 07, 2017: Common Cerebral White Matter Abnormalities Found in Children with Autistic Traits 36
Jul 16, 2017: Drug Combined with Care Program Seven Times Better at Reducing Alzheimer’s Symptoms than Drug Alone 38
Jun 26, 2017: Mechanism Shown to Reverse Disease in Arteries 39
Jun 26, 2017: Mayor De Blasio Announces $5 Million Grant for LIFESCI NYC Incubator 41
Jun 21, 2017: Identified Brain Circuitry Bridges Neural and Behavioral Roles in Post-Traumatic Stress Disorder 44
May 19, 2017: Erectile Dysfunction Medicines Do Not Cause Melanoma, Analysis of Large Studies Finds 45
May 19, 2017: Chronic Pain Amplifies the Brain’s Reaction to New Injuries 46
May 15, 2017: Certain Immune Reactions to Viruses Cause Learning Problems 47
Apr 10, 2017: Pancreatic Cancer Pathway Identified; Discovery May Broach New Era of Effective Immunotherapies for the Deadliest Major Cancer 48
Jan 25, 2017: Researchers Find New Way to Target Blood Stem Cell Cancers 49
Product News 51
Jul 10, 2017: NYU Langone Launches Major Interdisciplinary Program Targeting Pancreatic Cancer 51
Other Significant Developments 52
Jun 21, 2018: NYU Langone Health Introduces Telepsychiatry To Brooklyn Schools 52
May 23, 2018: Rusk Rehabilitation Launches Specialized Program to Optimize Quality of Life in Cancer Survivors 53
Jan 29, 2018: NYU Langone Health Launches New Lung Transplant Program 54
Dec 22, 2017: NYU Langone To Offer Heart Transplant Services At NYU Winthrop Hospital On Long Island 56
May 17, 2017: NYU Langone And NYU Winthrop Enhance Access To Maternal Fetal Medicine On Long Island 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Key Facts 2
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NYU Langone Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NYU Langone Medical Center, Deals By Therapy Area, 2012 to YTD 2018 9
NYU Langone Medical Center, Medical Devices Deals, 2012 to YTD 2018 10
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Vedanta Biosciences Enters into Agreement with NYU Langone Medical Center 12
Vedanta Biosciences Expands Agreement with NYU Langone Medical 13
NYU Langone Medical Center Acquires Huntington Medical 14
NYU Langone Medical Center, Key Competitors 15
NYU Langone Medical Center, Key Employees 16
NYU Langone Medical Center, Other Locations 17
NYU Langone Medical Center, Subsidiaries 17

List of Figures
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
NYU Langone Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
NYU Langone Medical Center, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[NYU Langone Medical Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Plexus Corp (PLXS):企業の財務・戦略的SWOT分析
    Plexus Corp (PLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Dechra Pharmaceuticals PLC:企業のM&A・事業提携・投資動向
    Dechra Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dechra Pharmaceuticals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Celonic AG-製薬・医療分野:企業M&A・提携分析
    Summary Celonic AG (Celonic), a subsidiary of JRS Pharma LP is a biotechnology company that provides contract development manufacturing organization services. The company’s services include development of cell lines and biotechnological production processes, full GMP analytics, and manufacture of ac …
  • Concept Packaging Group:企業の戦略・SWOT・財務分析
    Concept Packaging Group - Strategy, SWOT and Corporate Finance Report Summary Concept Packaging Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Chiba Bank Ltd:企業の戦略・SWOT・財務情報
    The Chiba Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Chiba Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pierrel Spa (PRL):製薬・医療:M&Aディール及び事業提携情報
    Summary Pierrel Spa (Pierrel) is a pharmaceutical company that offers contract services to biopharmaceutical and life sciences industries across the world. The company offers services in the areas of contract research, discovery of medicinal product candidates, clinical research and contract manufac …
  • American Greetings Corporation:企業の戦略的SWOT分析
    American Greetings Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Bridgford Foods Corporation:戦略・SWOT・企業財務分析
    Bridgford Foods Corporation - Strategy, SWOT and Corporate Finance Report Summary Bridgford Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • E.ON SE (EOAN):電力:M&Aディール及び事業提携情報
    Summary E.ON SE (E.ON), formerly E.ON AG, is an energy company that generates electricity, produces, stores, transports and supplies gas, and conducts trading, carbon sourcing, and electricity and gas distribution. It generates power from diverse fuel sources including wind, hydro, nuclear, coal, na …
  • Orchids Paper Products Co (TIS):企業の財務・戦略的SWOT分析
    Orchids Paper Products Co (TIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • TissueGen Inc:企業の製品パイプライン分析2018
    Summary TissueGen Inc (TissueGen) is a medical device company that develops fiber for advance drug delivery, nerve regeneration and tissue engineering. The company’s products comprise pharmaceutical fibers, growth factor fibers and stent. It offers pharmaceutical fibers and growth factor fibers. Tis …
  • CBT Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CBT Pharmaceuticals Inc (CBT) is a pharmaceutical company that develops innovative medicines for cancer indications. The company's pipeline products include CBT-101, cMet inhibitor is being developed to target the epithelial to mesenchymal transition pathway. Its CBT-101 is developed for var …
  • Votorantim SA:企業の戦略的SWOT分析
    Votorantim SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Aveng Ltd (AEG):企業の財務・戦略的SWOT分析
    Aveng Ltd (AEG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Taurus International MFG, Inc.:企業の戦略・SWOT・財務情報
    Taurus International MFG, Inc. - Strategy, SWOT and Corporate Finance Report Summary Taurus International MFG, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • CK Infrastructure Holdings Ltd (1038):石油・ガス:M&Aディール及び事業提携情報
    Summary CK Infrastructure Holdings Limited (CKI), a subsidiary of CK Hutchison Holdings Limited, is an infrastructure investment company. It holds diversified investment interests across various sectors including energy, rail transportation, water, waste management, and other infrastructure related …
  • Petroleos Mexicanos:企業の戦略的SWOT分析
    Petroleos Mexicanos - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Vanda Pharmaceuticals Inc (VNDA):企業の財務・戦略的SWOT分析
    Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Alibaba Group Holding Limited:企業の戦略・SWOT・財務情報
    Alibaba Group Holding Limited - Strategy, SWOT and Corporate Finance Report Summary Alibaba Group Holding Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆